Scott Howell

Scott Howell is a prominent figure in the health and pharmaceutical sectors, currently serving as a Board Member at ADVI Health and a Co-Founder and CEO at Synapse Sciences since August 2023. Howell is also an Advisory Board Member at Pear VC and hosts a podcast for Prescription for Better Access. Additionally, Howell provides expertise as a Life Sciences and Health Tech and Services Advisor at Blue Line Advisors, LLC, while holding the position of Professional Lecturer at the University of California, Berkeley since 2008. Previously, Howell was the Chief Strategy Officer for US Pharmaceuticals at Novartis and worked in various leadership roles at Jazz Pharmaceuticals, Cardinal Health, and Genentech. Educational credentials include an M.B.A. in Health Services Administration from Duke University, an M.D. from The Ohio State University, and a Bachelor's degree in Pre-Medicine from the University of Notre Dame.